Eversept Partners’s CATALENT, INC. CTLT Stock Holding History

Eversept Partners’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,000	Closed	-$90K	–	81
2022 Q4	$90K	Buy	+2,000	New	+$109K	0.01%	67

Other funds holding CTLT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Eversept Partners's CTLT Position: Q3 2023 in Review

Eversept Partners sold out of CATALENT, INC. (CTLT) in Q3 2023, closing a stake of 356,875 shares — an estimated $15.5M sold.

Eversept Partners first reported a position in CTLT in Q3 2020 and held it in 7 quarters. The position peaked at $37.7M in Q1 2023. 434 funds tracked by Wall St. Rank hold CTLT as of Q3 2023.

Eversept Partners reported no remaining CATALENT, INC. position as of Q3 2023 after selling out during the quarter.
Eversept Partners sold 356,875 CATALENT, INC. shares in Q3 2023, an estimated $15.5M.
Eversept Partners first reported a position in CATALENT, INC. in Q3 2020 and held it in 7 quarters.
Eversept Partners's CATALENT, INC. position peaked at $37.7M in Q1 2023.
434 funds tracked by Wall St. Rank held CATALENT, INC. as of Q3 2023.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.